Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to 0.43.

  • Dexcom's Equity Ratio rose 3357.89% to 0.43 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.43, marking a year-over-year increase of 3357.89%. This contributed to the annual value of 0.43 for FY2025, which is 3357.89% up from last year.
  • According to the latest figures from Q4 2025, Dexcom's Equity Ratio is 0.43, which was up 3357.89% from 0.36 recorded in Q3 2025.
  • Dexcom's 5-year Equity Ratio high stood at 0.43 for Q4 2025, and its period low was 0.31 during Q2 2023.
  • Over the past 5 years, Dexcom's median Equity Ratio value was 0.37 (recorded in 2022), while the average stood at 0.37.
  • Its Equity Ratio has fluctuated over the past 5 years, first crashed by 2877.91% in 2023, then surged by 3357.89% in 2025.
  • Over the past 5 years, Dexcom's Equity Ratio (Quarter) stood at 0.41 in 2021, then fell by 4.48% to 0.4 in 2022, then decreased by 16.48% to 0.33 in 2023, then fell by 1.8% to 0.32 in 2024, then surged by 33.58% to 0.43 in 2025.
  • Its last three reported values are 0.43 in Q4 2025, 0.36 for Q3 2025, and 0.35 during Q2 2025.